You are here

Article Text

Article menu
Download PDFPDF
Brief encounters
Brief encounters
  1. Helen Ward,
  2. Rob Miller

    https://doi.org/10.1136/sti.2009.038570

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      PHOSPHODIESTERASE TYPE 5 INHIBITOR USE AND CONDOM BREAKAGE—IS THERE A LINK?

      Phosphodiesterase type 5 inhibitor (PDE5i) drugs are widely used to treat erectile dysfunction. Use of these drugs has been associated with increased rates of high-risk sexual behaviour and HIV transmission in some men. Crosby and colleagues carried out a study to see whether condom breakage as a result of enhanced erections may be a factor. They studied heterosexual men who reported condom use and compared those who used PDE5i with those who did not. Condom failures occurred 12% of the time in PDE5i users compared with 5% in controls. After adjusting for potential confounders, men using PDE5i were approximately four times more likely to report condom breakage. The authors suggest that men using the drug should be advised on techniques to reduce breakage. See also the accompanying Commentary by Goldmeier and Richardson.

      See pages 404 and p 405

      WHO STILL GETS GONORRHOEA?

      Delpech …

      View Full Text

      Linked Articles